Additional Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    University of Colorado, Anschutz Medical Campus
    Aurora CO. 80045
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Thomas Jefferson University
    Philadelphia PA. 19107
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Columbia University
    New York NY. 10032
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    CIC Mauricie
    Trois-Rivières QC. G8T 7A1
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Centre for Lung Health
    Vancouver V5Z1M9
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Medical University of South Carolina
    Charleston SC. 29425
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Renstar Medical Research
    Ocala FL. 34470
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    University of Cincinnati
    Cincinnati OH. 45267
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    The University of Kansas Medical Center
    Kansas OH. 66160
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Southeastern Research Center
    Winston-Salem NC. 27103
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Dynamic Drug Advancement
    Ajax ON.
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Washington
    Seattle WA. 98195
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of British Columbia
    Vancouver BC. V6Z 1Y6
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Calgary
    Calgary AB. T2N 4Z6
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Texas Southwestern
    Dallas TX. 75390
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Virginia
    Charlottesville VA. 22908
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Michigan
    Ann Arbor MI. 48109
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Massachusetts Chan Medical School
    Worcester MA. 01655
    View Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    Mayo Clinic, Rochester
    Rochester MN. 55902
    View Details